期刊文献+

2型糖尿病伴周围神经病变患者外周血单个核细胞中醛糖还原酶mRNA水平测定 被引量:9

Aldose reductase gene expression in peripheral blood mononuclear cells and its association with peripheral neuropathy in type 2 diabetic patients
下载PDF
导出
摘要 目的探讨外周血单个核细胞(PBMC)中醛糖还原酶(AR)mRNA水平与2型糖尿病并发周围神经病变的关系。方法用RT-PCR法检测32例2型糖尿病患者及35名正常对照者PBMC中ARmRNA水平,用肌电图检测腓神经传导速度,根据神经传导速度有无减慢将糖尿病患者分为普通糖尿病组和糖尿病神经病变组。结果2型糖尿病患者PBMC中ARmRNA的表达量(0.59±0.56)高于正常对照组(0.30±0.11),P=0.003;糖尿病是否伴神经病变患者之间ARmRNA的表达量无差别。结论2型糖尿病患者PBMC中ARmRNA表达水平增高与是否伴神经病变无关。 Objective To investigate the relationship between the levels of aldose reductase(AR) mRNA in peripheral blood mononuclear cells (PBMC) and the peripheral neuropathy in type 2 diabetic patients. Methods The levels of AR mRNA in PBMC was determined by RT-PCR, and the nerve conduction velocity (NCV) in the calf nerve was measured. A total of 32 patients with type 2 diabetes and 35 normal controls were studied. The diabetic patients were divided into 2 groups patients with normal NCV and those with delayed NCV. Results AR mRNA levels in PBMC of type 2 diabetic patients was significantly higher than those of normal controls (0.59±0.56 vs 0.30±0.11, P=0.003). There was no significant difference in AR mRNA levels between two groups of diabetics.Conclusion Type 2 diabetic patients have a significantly higher expression of AR mRNA in PBMC than that in normal controls, but that is not related to the presence of diabetic peripheral neuropathy.
作者 何敏慧 李红
出处 《浙江医学》 CAS 2004年第3期167-168,200,共3页 Zhejiang Medical Journal
关键词 2型糖尿病 周围神经病变 外周血 单个核细胞 醛糖还原酶 MRNA RT-PCR 胰岛素 Diabetic neuropathy Aldose reductase RT-PCR
  • 相关文献

参考文献6

  • 1Simmons Z,Feldman EL.Update on diabetic neuropathy.Curr Opin Neurol,2002, 15(5): 595.
  • 2Yagihashi S,Yamagishi SI,Wada RR,et al.Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor.Brain,2001,124(Pt 12): 2448.
  • 3Shimizu H,Ohtani KI,Tsuchiya T,et al.Aldose reductase mRNA expression is associated with rapid development of diabetic microangiopathy in Japanese Type 2 diabetic (T2DM) patients.Diabetes Nutr Metab,2000.13(2):75.
  • 4Shimoshige Y,Ikuma K,Yamamoto T,et al.The effects of zenarestat, an aldose reductase inhibitor,on peripheral neuropathy in Zucker diabetic fatty rats.Metabolism,2000,49(11): 1395.
  • 5Kato N,Mizuno K,Makino M,et al.Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats.Diabetes Res Clin Pract,2000,50(2): 77.
  • 6Obrosova IG,van Huysen C,Fathallah L,et al.An aldose reductase inhibitor reverses early diabetes-induced changes inperipheral nerve function,metabolism,and antioxidative defense.Faseb J,2002,16(1):123.

同被引文献75

引证文献9

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部